Analyst Reco. Novavax, Inc.

Equities

NVAX

US6700024010

Real-time Estimate Cboe BZX Other stock markets 17:39:51 02/05/2024 BST			5-day change	1st Jan Change
4.675 ^USD	+0.11%		+18.35%	-2.60%

04-15	Sector Update: Health Care Stocks Gain Monday Afternoon	MT
04-15	Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla...

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novavax Shareholder Shah Capital Pushes to Add 2 Nominees to Company's Board	04-15	MT
Hedge fund Shah Capital urges Novavax board shake-up, FT says	04-15	RE
Hedge fund Shah Capital urges board shake-up at Novavax over struggling Covid vaccine, FT reports	04-15	RE
HC Wainwright Cuts Price Target on Novavax to $19 From $35, Keeps Buy Rating	03-01	MT
B. Riley Trims Novavax's PT to $11 From $12 After Reaching Settlement on Gavi Arbitration Dispute, Keeps Buy Rating	02-23	MT
WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge	01-12	RE
Job losses delight investors	12-06
B. Riley Lowers Novavax's Price Target to $12 From $15 After Near-Term COVID-19 Sales Estimate Revisions, Maintains Buy Rating	11-10	MT
Wall Street ends lower on healthcare losses, interest rate jitters	17/08/23	RE
B. Riley Upgrades Novavax to Buy From Neutral After Above-Consensus Q2 Beat, Says Turnaround Progressing; Retains $15 PT	09/08/23	MT
US govt tells vaccine makers to price updated COVID shots reasonably	13/07/23	RE
Will the Fed follow Australia's decision to hike rates?	06/06/23
B. Riley Raises Novavax's PT to $15 From $10, Says Q1 Financial Update 'Not As Bad As Feared'; Keeps Neutral Rating	10/05/23	MT
S&P, Nasdaq weak as manufacturing stokes Fed concerns	01/03/23	RE
B. Riley Downgrades Novavax to Neutral From Buy, Lowers Price Target to $10 From $29	01/03/23	MT
B. Riley Cuts Novavax's Price Target to $29 From $37, Maintains Buy Rating	17/02/23	MT
B. Riley Lowers Novavax's Price Target to $37 From $74, Keeps Buy Rating	09/01/23	MT
North American Morning Briefing : Rough Start For Futures, Focus Still on Rate Path	15/12/22	DJ
B. Riley Lowers Novavax's Price Target to $74 From $83, Keeps Buy Rating	10/11/22	MT
B. Riley Lowers Novavax's PT to $83 From $126 to Reflect Current Realities of COVID Booster Market Dynamics, Cuts Near-Term Estimates; Maintains Buy Rating	14/10/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Novavax Doubtful About Its Financial Future

February 28, 2023 at 10:09 pm